Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2025 05:00 ET | Source: Artios Pharma

Artios Receives U.S. FDA Fast Track Designation for alnodesertib in ATM-negative Metastatic Colorectal Cancer (mCRC)

U.S. Fast Track designation underscores the strength of the alnodesertib clinical data generated to date and the high degree of unmet need in 3L mCRC CAMBRIDGE, United Kingdom and NEW YORK, September...
September 19, 2025 08:05 ET | Source: Imunon, Inc.

IMUNON to Present New Translational Data of IMNN-001 Supporting Phase 3 Trial of Immunotherapy for Ovarian Cancer at AACR Special Conference in Cancer Research

OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treated LAWRENCEVILLE, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a...
September 16, 2025 13:00 ET | Source: UTR Therapeutics Inc.

UTR Therapeutics Publishes Landmark Preclinical Data in Frontiers in Pharmacology Supporting IND Submission for First-in-Class c-MYC RNA Therapeutic

UTR Therapeutics Inc Publishes Data supporting US FDA IND for a First-in-Human Clinical Trial of mRNA destabilizing drug targeting c-MYC driven cancer
September 04, 2025 10:00 ET | Source: The Wistar Institute

The Wistar Institute Appoints Katherine Aird, Ph.D., to Ellen and Ronald Caplan Cancer Center

Philadelphia, PA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, announces the appointment of...
August 12, 2025 09:30 ET | Source: Artios Pharma

Artios Pharma Appoints Michael T. Andriole as CEO and Director to Advance Alnodesertib (ART0380) into Late-stage Development

Mike Andriole brings approximately 25 years of experience in the biopharmaceutical industry and a successful track record of delivering new first-in-class oncology therapies in indications of high...
July 31, 2025 09:08 ET | Source: ODW Logistics

ODW Logistics Moves More Than Miles for Pelotonia 2025

COLUMBUS, Ohio, July 31, 2025 (GLOBE NEWSWIRE) -- ODW Logistics (ODW), a leading national third-party logistics (3PL) provider, is proud to continue its partnership with Pelotonia, supporting Ride...
July 29, 2025 11:00 ET | Source: University Hospital Foundation

Kaye Competition awards more than $1,000,000 to Edmonton-based researchers

Edmonton, AB, July 29, 2025 (GLOBE NEWSWIRE) -- The University Hospital Foundation (The Foundation) is pleased to announce the recipients of the 2024 Kaye Competition, which funds research and...
July 22, 2025 06:00 ET | Source: Bunzl Canada Inc

25 ans d’espoir pour la recherche sur les tumeurs cérébrales pédiatriques

Les dons recueillis lors du tournoi de golf annuel de Bunzl Canada approchent les 2 M$ en 2025 BURLINGTON, Ontario, 22 juill. 2025 (GLOBE NEWSWIRE) -- Bunzl Canada a récemment tenu son 25e...
July 22, 2025 06:00 ET | Source: Bunzl Canada Inc

25 Years of Hope for Pediatric Brain Tumour Research

Bunzl Canada’s Annual Golf Event Donations Approach $2M in 2025 BURLINGTON, Ontario, July 22, 2025 (GLOBE NEWSWIRE) -- Bunzl Canada recently hosted its 25th annual Ripple of Hope Golf...
July 14, 2025 10:00 ET | Source: Verified Market Research

In Situ Hybridization Market is expected to generate a revenue of USD 3.38 Billion by 2031, Globally, at 8.97% CAGR: Verified Market Research®

Lewes, Delaware, July 14, 2025 (GLOBE NEWSWIRE) -- The Global In Situ Hybridization Market Size is projected to grow at a CAGR of 8.97% from 2024 to 2031, according to a new report published by...